Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Ziad Bakouny et al.|Nature Reviews Clinical Oncology|2021Cited by 382
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, Srinivas R. Viswanathan, Stephen Tang et al.|Nature Communications|2021Cited by 167
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A. McGregor, Toni K. Choueiri, Rana R. McKay et al.|Journal of Clinical Oncology|2019Cited by 147
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell CarcinomaLaure Hirsch, Toni K. Choueiri, Nieves Martínez Chanzá et al.|JAMA Oncology|2021Cited by 95
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid TumorsSarah Abou Alaiwi, Toni K. Choueiri, Amin H. Nassar et al.|Cancer Immunology Research|2020Cited by 79